Sao et al. observed a reduced mRNA level of MEF2C in Japanese patients with AD, but its methylation rate had no significant difference between AD and control, different from our findings of MEF2C being hypermethylated-downregulated in AD (Sao et al., 2018). Here, MEF2C is linked to Alzheimer disease.